Application 220326
- Type
- ANDA
- Sponsor
- APPCO PHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | VILOXAZINE HYDROCHLORIDE | VILOXAZINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE | 200MG | No | No |
| 003 | VILOXAZINE HYDROCHLORIDE | VILOXAZINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE | 150MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QELBREE | VILOXAZINE HYDROCHLORIDE | Supernus Pharmaceuticals, Inc | aedf408d-0f84-418d-9416-7c39ddb0d29a | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | VILOXAZINE HYDROCHLORIDE |